KLRK1 and head and neck squamous cell carcinoma: Indeed, our incubations (24 h) of activated NK cells with sMICA analogs or PP containing increased sMICA resulted in decreased NKG2D expression followed by impaired NKG2D-dependent killing activity against associated HNSCC cells.